Monthly archives: January, 2018

Dubai Airports reports continued growth in November 2017

Dubai, UAE – January 4, 2018 – The upward trend in passenger traffic continued at Dubai International (DXB) with the hub welcoming close to 7 million passengers in November 2017, according to the monthly traffic report issued by operator Dubai Airports. Passenger traffic at DXB reached 6,953,596 in November compared to 6,581,805 recorded in the …

TUV Rheinland to test for compliance of imported toys in India

  Accredited by NABL to test for new IS 9873 and IS 15644 Standards notified by DGFT    Bengaluru,  4th January, 2018: TUV Rheinland India, a subsidiary of the TUV Rheinland Group, Germany, a worldwide leader in testing, training, inspection, consulting and certification, announced that its testing laboratory at Gurugram has been accredited by the …

Cryptocurrency Trading Platform Qurrex Announces Strategic Partnership With KYC Legal

January 03, 2018 – Amsterdam   Qurrex, a first of its kind exchange platform designed to meet challenges of the dramatic growth of cryptocurrency trading, has announced its strategic partnership with KYC legal to secure the digital transparency of cryptocurrency transactions. Per the agreement, the parties will work together to meet the growing demand for authorization …

The Finnish first-screen technology and leading Malaysian OTT-platform to bring the innovative social layer to its audience.

  Kuala Lumpur, Malaysia – On Friday the 8th of December, tonton announced a strategic partnership with Camment® in front of Malaysian media, top influencers, celebrities and Media Prima management. Tonton, Malaysia’s 1st and largest home grown video streaming service by the country’s leading Malaysian media house, Media Prima Berhad, with over 7.5 million registered users, will be the …

WHO prequalifies breakthrough vaccine for typhoid

3 January 2018 – At the end of December 2017, WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech’s Typbar-TCV®. Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting immunity than older vaccines, require fewer doses, and can be given to young children through routine childhood immunization programs. The fact that the vaccine has …